George Prendergast

8PUBLICATIONS
69CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food properties (incl. characteristics and health benefits)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Aug 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.

Christopher W Schultz, Grace A McCarthy, Teena Nerwal

|Feb 24, 2021
IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization.

Souvik Dey, Arpita Mondal, James B DuHadaway

|Jun 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.

Erik Ladomersky, Lijie Zhai, Kristen L Lauing

|Feb 28, 2019
Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine.

Kaylend Manley, Arturo Bravo-Nuevo, Allyson R Minton

Pageof 2